IGF1R and central nervous system cancer: In 1996, Resnicoff and co-workers [3] demonstrated that C6 glioma cells expressing an antisense IGF-1R RNA were no longer tumorigenic in syngeneic rats, protected them from subsequent tumor re-challenge, and caused regression of established subcutaneous tumors.